Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
- General Info
- Route
- ATC
- Indications
- Composition
- Side Effects
- Alternative Products
- AP Price Chart
- Alternative Treatments
- Available In
-
Contraindicated
Not recommended
Manque de données
| Candesartan/HCTZ 8/12.5mg Biogaran : | |
| Type | Medicine Authorised |
| Originator | Atacand Plus 16/12.5mg |
| Agent | Commercial and Trading Ressources (CTR) |
| Distributor | Commercial and Trading Ressources (CTR) |
| Laboratory | Biogaran |
| Responsible Party | Laboratoires Biogaran |
| Origin | France |
| Manufacturer | Bluepharma Industria Farmaceutica SA |
| Manufacturing Type | G |
| Origin | Portugal |
| ATC | C09DA06 |
Candesartan/HCTZ 8/12.5mg Biogaran :
Candesartan/HCTZ 8/12.5mg Biogaran :
Candesartan/HCTZ 8/12.5mg Biogaran :
Candesartan/HCTZ 8/12.5mg Biogaran :
Candesartan/HCTZ 8/12.5mg Biogaran :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Agitation | Rare |
| Agranulocytosis | Very rare |
| ALT increased | Uncommon |
| Anaphylactic reactions | Rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
| Anorexia | Uncommon |
| Aplastic anemia | Rare |
| Appetite lost | Uncommon |
| Arrhythmia | Rare |
| Arthralgia (Pain joint) (Joint ache) | Very rare |
| AST increased | Very rare |
| Back pain | Very rare |
| Blood cholesterol increased | Common |
| Blood sodium decreased | Not known |
| Blood triglycerides increased | Common |
| Bone marrow depression | Rare |
| Cephalea | Very rare |
| Constipation | Uncommon |
| Cutaneous lupus erythematosus-like reactions | Rare |
| Cutaneous vasculitis | Rare |
| Depression | Rare |
| Diarrhoea (Diarrhea) | Uncommon |
| Fever | Rare |
| Gastric irritation (Stomach irritation) | Uncommon |
| Glucosuria (Glycosuria) | Common |
| Haemoglobin decreased | Very rare |
| Haemolytic anemia | Rare |
| Hepatic dysfunction | Very rare |
| Hepatic enzyme increased | Very rare |
| Hepatitis | Very rare |
| Hyperglycaemia | Common |
| Hyperkalaemia | Very rare |
| Hyperuricaemia | Common |
| Hypokalaemia | Common |
| Hyponatraemia (Hyponatremia) | Common |
| Interstitial nephritis | Rare |
| Intrahepatic cholestatic jaundice | Rare |
| Kidney function abnormal | Very rare |
| Leucopenia (Leukopenia) | Very rare |
| Lightheadedness | Common |
| Lung disease | Rare |
| Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
| Muscle spasms | Rare |
| Myalgia | Very rare |
| Nausea | Very rare |
| Necrotizing angiitis | Rare |
| Neutropenia | Very rare |
| Orthostatic hypotension | Uncommon |
| Pancreatitis | Rare |
| Paraesthesia (paresthesia) | Rare |
| Photosensitivity | Uncommon |
| Platelet count decreased (Thrombocyte count decreased) | Rare |
| Pruritus | Very rare |
| Pulmonary oedema | Rare |
| Reactivation of cutaneous lupus erythematosus | Rare |
| Renal insufficiency | Very rare |
| Respiratory distress | Rare |
| Serum creatinine increased | Not known |
| Serum potassium increased | Not known |
| Serum urea increased | Common |
| Skin Eruption | Uncommon |
| Sleep disorder (Sleep disturbance) | Rare |
| Urticaria | Uncommon |
| Vasculitis | Rare |
| Vertigo | Common |
| Vision blurred | Rare |
| Weakness | Common |
Candesartan/HCTZ 8/12.5mg Biogaran :
| ▲ Most Expensive |
| ▼ Least Expensive |
| P.P. = | Public Price |
| P/U = | Price Per Unit |
| - Products with same active ingredients |
| - Products with same strength |
| - Products with same route of administration |
| NB : Products With Same Indication |
Different Units By MoH Code
Candesartan/HCTZ 8/12.5mg Biogaran MoH 10113 :
| Form | Tablet |
| Package Size | Box of 30 |
| Strength | 8mg/12.5mg |
| Public Price | 327897.57 L.L. |
| Stratum | A1 |
| NSSF | ✘ |
| Quarantine | ✘ |
| Reg. Number | 83318/1 |
| Submission date | 14/06/2018 |
| Registration Year | 19/12/2018 |
| Pending Year | 13/09/2018 |
| Pending Reason | Incomplete file |
Price Comparison
| ● Country: | Lebanon | |
| ● Form: | Tablet | |
| ● Package Size: | Box of 30 | |
| ● Public Price: | 327897.57 LBP | ( 327,897.57 LBP ) |
| ● Pack size unit used: | 30 | |
| ● Cost/Unit: | 10929,92 LBP | ( 10,929.00 LBP ) |
| ● Pricing Date: | 13/06/2024 |
| ● Country: | France | |
| ● Package Size: | 30 | |
| ● Public Price: | 4.77 EUR | ( 462,098.52 LBP ) |
| ● Pack size unit used: | 30 | |
| ● Cost/Unit: | 0,159 EUR | ( 0.00 LBP ) |
| ● Reference: | ansm | |
| ● Pricing Date: | 15/05/2021 | |
| ● Type: | Medicine Authorised |
| ● Country: | Portugal | |
| ● Package Size: | 30 | |
| ● Public Price: | 8.65 EUR | ( 837,977.40 LBP ) |
| ● Pack size unit used: | 30 | |
| ● Cost/Unit: | 0,2883 EUR | ( 0.00 LBP ) |
| ● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde | |
| ● Pricing Date: | 02/06/2020 | |
| ● Type: | Medicine Authorised |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
